GE HealthCare, a subsidiary of General Electric, is a leading player in the global healthcare industry, headquartered in the United States. Founded in 1892, the company has evolved significantly, marking key milestones such as the introduction of advanced imaging technologies and innovative patient monitoring systems. With a strong presence in North America, Europe, and Asia, GE HealthCare focuses on medical imaging, monitoring, biomanufacturing, and digital solutions. Its core products, including MRI machines, ultrasound systems, and healthcare IT solutions, are renowned for their cutting-edge technology and reliability. As a pioneer in healthcare innovation, GE HealthCare has consistently maintained a strong market position, recognised for its commitment to improving patient outcomes and operational efficiency in healthcare settings worldwide.
How does GE HealthCare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
GE HealthCare's score of 96 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, GE HealthCare reported total greenhouse gas emissions of approximately 6.07 trillion kg CO2e, comprising 221 billion kg CO2e from Scope 1, 116 million kg CO2e from Scope 2, and about 6.07 trillion kg CO2e from Scope 3 emissions. This data reflects a significant operational footprint, with Scope 3 emissions being the predominant contributor. GE HealthCare has set ambitious climate commitments, aiming to achieve net zero emissions across its value chain by 2050. The company has established interim targets to reduce its operational greenhouse gas emissions (Scope 1 and 2) by 42% and Scope 3 emissions from purchased goods and services, upstream transportation and distribution, business travel, and use of sold products by 25% by 2030, using 2022 as the baseline year. Additionally, GE HealthCare aims to reduce its Scope 1 and 2 emissions to 50% of its 2019 levels by 2030. The company has also committed to a long-term reduction of 90% in absolute Scope 1, 2, and 3 emissions by 2050, compared to a 2022 baseline. These targets align with the Science Based Targets initiative (SBTi) and reflect GE HealthCare's commitment to addressing climate change within the healthcare sector.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 137,254,000 | 000,000,000 | 000,000,000 | 000,000,000,000 | 000,000,000,000 | 000,000,000,000 |
| Scope 2 | 192,207,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 0,000,000,000 | 0,000,000,000,000 | 0,000,000,000,000 | 0,000,000,000,000,000 |
GE HealthCare's Scope 3 emissions, which increased significantly last year and increased significantly since 2021, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with detailed category breakdown helping identify key emission sources across their value chain.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
GE HealthCare has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


Common questions about GE HealthCare's sustainability data and climate commitments